Glycinorm-m 40 Tablet

GLYCINORM-M 40 TABLET

Name:

• Brand Name: GLYCINORM-M 40 TABLET
• Common Name: Gliclazide and Metformin Tablets

Composition: GLYCINORM-M 40 TABLET contains two active ingredients:

• Gliclazide (40 mg)
• Metformin (500 mg)

Uses: This medicine is prescribed for the management of Type 2 Diabetes Mellitus in adults, particularly when diet and exercise alone are insufficient to control blood sugar levels. It works by increasing insulin release from the pancreas and reducing glucose production in the liver, while also improving the body's sensitivity to insulin. GLYCINORM-M 40 TABLET also helps reduce the risk of diabetes-related complications such as heart disease, nerve damage, kidney damage, and eye damage.

Dosage and Administration: GLYCINORM-M 40 TABLET should be taken orally with or just before meals, as directed by a healthcare professional. It is typically administered once or twice daily. The tablet should be swallowed whole with a glass of water and not chewed, crushed, or broken. Regular monitoring of blood sugar levels is recommended during treatment.

Side Effects:

• Common Side Effects: Hypoglycemia (low blood sugar), which may present as dizziness, sweating, palpitations, hunger pangs, headache, or shaking; nausea; vomiting; diarrhea; abdominal pain; flatulence; loss of appetite; rash; and metallic taste.
• Serious Side Effects: Rare but serious side effects include lactic acidosis (symptoms like muscle pain, weakness, difficulty breathing, feeling cold, stomach pain, or slow heart rate) and, with long-term use, potential Vitamin B12 deficiency.

Precautions: GLYCINORM-M 40 TABLET is not recommended for individuals with known allergies to its components, Type 1 diabetes, diabetic ketoacidosis, severe kidney or liver impairment, metabolic acidosis, or severe heart disease. It should be used with caution during breastfeeding and is not recommended during pregnancy. Alcohol consumption should be avoided or limited as it can increase the risk of hypoglycemia and lactic acidosis. Patients should carry a source of sugar to counteract unexpected low blood sugar levels. Do not stop taking this medicine without consulting a doctor.

Storage: Store GLYCINORM-M 40 TABLET in a cool and dry place, away from direct sunlight, at temperatures below 30°C. Keep it out of the sight and reach of children.

GLYCINORM-M 40 TABLET: Frequently Asked Questions

What is GLYCINORM-M 40 TABLET used for?

GLYCINORM-M 40 TABLET is primarily used to treat Type 2 diabetes mellitus in adults. It helps manage blood sugar levels, especially when diet, exercise, and single-medicine therapy are not enough. This medication also helps reduce the risk of diabetes-related complications such as kidney damage, nerve damage, eye damage, heart attack, and stroke.

How does GLYCINORM-M 40 TABLET work?

GLYCINORM-M 40 TABLET is a combination of two anti-diabetic drugs: Gliclazide and Metformin. Gliclazide increases the amount of insulin released by the pancreas. Metformin works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's response to insulin. Together, they prevent blood glucose levels from rising too high, thereby keeping diabetes under control.

What is the usual dosage for GLYCINORM-M 40 TABLET?

GLYCINORM-M 40 TABLET should be taken as prescribed by your doctor. It is typically taken with food, usually once or twice daily at the same time each day to avoid stomach upset. Do not chew, crush, or break the tablet; swallow it whole with a glass of water. Your doctor will determine the appropriate dose, which may change based on your blood sugar levels and overall condition.

What are the possible side effects of GLYCINORM-M 40 TABLET?

Common side effects can include hypoglycemia (low blood sugar levels, characterized by dizziness, sweating, palpitations, hunger pangs), nausea, vomiting, diarrhea, abdominal pain, metallic taste, headache, and dizziness. Serious but rare side effects like lactic acidosis can also occur. If you experience persistent or severe side effects, consult your doctor.

Is GLYCINORM-M 40 TABLET safe during pregnancy or breastfeeding?

GLYCINORM-M 40 TABLET is generally not recommended for use during pregnancy as animal studies have shown harmful effects on the developing baby, and it can harm the unborn baby. Its use should be avoided during breastfeeding as it is not known if the medicine or its metabolites are excreted in breast milk and may cause harm to the newborn. Always consult your doctor before using this medicine if you are pregnant or breastfeeding.

Can GLYCINORM-M 40 TABLET be taken with other medications?

GLYCINORM-M 40 TABLET can interact with several medications. For example, other antidiabetic agents (like insulin), beta-blockers, ACE inhibitors, and certain antifungals (like fluconazole) may increase its blood sugar-lowering effect. Inform your doctor about all medicines, supplements, and herbal products you are taking to avoid potential interactions.

What precautions should be taken with GLYCINORM-M 40 TABLET?

It is important to take this medicine with food to avoid stomach upset. Regular monitoring of blood sugar levels is crucial. You should always carry a fast-acting source of glucose (like sugar candy or fruit juice) to counteract unexpected low blood sugar levels (hypoglycemia). Avoid consuming alcohol as it can increase the risk of hypoglycemia and alter the medicine's effectiveness. Caution is advised for patients with kidney or liver disease, heart conditions, or G6PD deficiency.

What happens if a dose is missed?

If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for the missed one, as this can cause a drastic drop in blood glucose levels, which can be dangerous.

How should GLYCINORM-M 40 TABLET be stored?

Store GLYCINORM-M 40 TABLET in a cool, dry place, away from direct sunlight and moisture, preferably below 25°C or 30°C. Keep it out of the sight and reach of children and pets.